NCT05305014View on ClinicalTrials.gov

Contribution of Inflammation and Neuronal Integrity Markers in Patients With First-episode Conversive Motor Disorder

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

April 15, 2022

Study Completion Date

April 15, 2022

Conditions
Conversion Disorder
Interventions
DIAGNOSTIC_TEST

blood inflammatory markers (TNF-α, IL1ra, RsIL-2, IL-6, IL-10, IL-18, IFNγ, MCP-1/CCL2 GFAP)

Bioassays of blood inflammatory markers (TNF-α, IL1ra, RsIL-2, IL-6, IL-10, IL-18, IFNγ, MCP-1/CCL2 GFAP) from sera babcocked in the HYCORE mother study.

Trial Locations (1)

30029

Ismael CONEJERO, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER